These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 15893021)
1. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins. Torre MH; Gambino D; Araujo J; Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Vega AM; Abram U; Costa-Filho AJ Eur J Med Chem; 2005 May; 40(5):473-80. PubMed ID: 15893021 [TBL] [Abstract][Full Text] [Related]
2. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives. Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs. Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490 [TBL] [Abstract][Full Text] [Related]
4. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents. Urquiola C; Gambino D; Cabrera M; Lavaggi ML; Cerecetto H; González M; de Cerain AL; Monge A; Costa-Filho AJ; Torre MH J Inorg Biochem; 2008 Jan; 102(1):119-26. PubMed ID: 17804074 [TBL] [Abstract][Full Text] [Related]
5. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds. Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of some novel CoII and CoIII complexes by tribochemical reactions using KI with some derivatives of thiosemicarbazide complexes derived from Girard's T and P. Al-Ashqar SM; Mostafa MM Spectrochim Acta A Mol Biomol Spectrosc; 2008 Dec; 71(4):1321-6. PubMed ID: 18534903 [TBL] [Abstract][Full Text] [Related]
7. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium. Urquiola C; Vieites M; Aguirre G; Marín A; Solano B; Arrambide G; Noblía P; Lavaggi ML; Torre MH; González M; Monge A; Gambino D; Cerecetto H Bioorg Med Chem; 2006 Aug; 14(16):5503-9. PubMed ID: 16709457 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and dioxygen reactivity of copper(I) complexes with glycoligands. Damaj Z; Cisnetti F; Dupont L; Henon E; Policar C; Guillon E Dalton Trans; 2008 Jun; (24):3235-45. PubMed ID: 18688422 [TBL] [Abstract][Full Text] [Related]
9. Synthetic, spectral, magnetic and in vitro cytotoxic activity studies of cobalt(II) complexes with cytokinin derivatives: X-ray structure of 6-(3-methoxybenzylamino)purinium chloride monohydrate. Trávnícek Z; Klanicová A; Popa I; Rolcík J J Inorg Biochem; 2005 Mar; 99(3):776-86. PubMed ID: 15708799 [TBL] [Abstract][Full Text] [Related]
10. Spectroscopic characterization of copper(II) complexes of indoxyl N(4)-methyl thiosemicarbazone. Chandra S; Kumar U Spectrochim Acta A Mol Biomol Spectrosc; 2004 Oct; 60(12):2825-9. PubMed ID: 15350918 [TBL] [Abstract][Full Text] [Related]
11. Structural and electronic differences of copper(I) complexes with tris(pyrazolyl)methane and hydrotris(pyrazolyl)borate ligands. Fujisawa K; Ono T; Ishikawa Y; Amir N; Miyashita Y; Okamoto K; Lehnert N Inorg Chem; 2006 Feb; 45(4):1698-713. PubMed ID: 16471983 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and cytotoxic activity of copper(II) and platinum(II) complexes of 2-benzoylpyrrole and X-ray structure of bis[2-benzoylpyrrolato(N,O)]copper(II). Rubino S; Petruso S; Pierattelli R; Bruno G; Stocco GC; Steardo L; Motta M; Passerotto M; Giudice ED; Gulì G J Inorg Biochem; 2004 Dec; 98(12):2071-9. PubMed ID: 15541496 [TBL] [Abstract][Full Text] [Related]
13. DNA binding studies of novel Copper(II) complexes containing L-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells. Chauhan M; Banerjee K; Arjmand F Inorg Chem; 2007 Apr; 46(8):3072-82. PubMed ID: 17378549 [TBL] [Abstract][Full Text] [Related]
14. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides. Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668 [TBL] [Abstract][Full Text] [Related]
15. Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60. Angelusiu MV; Almajan GL; Rosu T; Negoiu M; Almajan ER; Roy J Eur J Med Chem; 2009 Aug; 44(8):3323-9. PubMed ID: 19356828 [TBL] [Abstract][Full Text] [Related]
16. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III. Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420 [TBL] [Abstract][Full Text] [Related]
17. Copper(II) complexes of tridentate pyridylmethylethylenediamines: role of ligand steric hindrance on DNA binding and cleavage. Raja A; Rajendiran V; Uma Maheswari P; Balamurugan R; Kilner CA; Halcrow MA; Palaniandavar M J Inorg Biochem; 2005 Aug; 99(8):1717-32. PubMed ID: 16039720 [TBL] [Abstract][Full Text] [Related]
18. Structures, spectra, and DNA-binding properties of mixed ligand copper(II) complexes of iminodiacetic acid: the novel role of diimine co-ligands on DNA conformation and hydrolytic and oxidative double strand DNA cleavage. Selvakumar B; Rajendiran V; Uma Maheswari P; Stoeckli-Evans H; Palaniandavar M J Inorg Biochem; 2006 Mar; 100(3):316-30. PubMed ID: 16406550 [TBL] [Abstract][Full Text] [Related]
19. Molecular structure, bioavailability and bioactivity of [Cu(o-phen)2(cnge)](NO3)2.2H2O and [Cu(o-phen)(cnge)(H2O)(NO3)2] complexes. Ferrer EG; López Tévez LL; Baeza N; Correa MJ; Okulik N; Lezama L; Rojo T; Castellano EE; Piro OE; Williams PA J Inorg Biochem; 2007 May; 101(5):741-9. PubMed ID: 17331582 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand. Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]